TapewireFind a company

person · Reporting owner

Wilkinson Scott

Disclosed activity across 1 company

Tapewire entity
144950
SEC CIK
0001596082

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Inogen IncINGN · Entity 2083Director · President and CEODecember 01, 2020December 03, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Inogen Inc

Report date December 01, 2020 · Filed December 03, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect30,737 Ending reported balance After 2020-12-01 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2020-12-01 · Tax withholding · Disposed 352 · Balance 31,208

F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020.

Row 2 · 2020-12-01 · Tax withholding · Disposed 220 · Balance 30,988

F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020.

Row 3 · 2020-12-01 · Tax withholding · Disposed 251 · Balance 30,737

F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020.

Filing footnotes · ownership attribution and instrument terms

F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 01, 2020 Filed Dec 3, 2020 00:07 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 251 $35.28 $8,855.28
Disclosure

SEC source: 0001209191-20-061300 · doc4.xml · nonDerivative · entry 3

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,737

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 00:07 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 220 $35.28 $7,761.60
Disclosure

SEC source: 0001209191-20-061300 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,988

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 00:07 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 352 $35.28 $12,418.56
Disclosure

SEC source: 0001209191-20-061300 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,208

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 23:13 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 251 $28.94 $7,263.94
Disclosure

SEC source: 0001209191-20-049264 · doc4.xml · nonDerivative · entry 3

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,560

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 23:13 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 220 $28.94 $6,366.80
Disclosure

SEC source: 0001209191-20-049264 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,811

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 23:13 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 351 $28.94 $10,157.94
Disclosure

SEC source: 0001209191-20-049264 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,031

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 22:28 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 251 $38.55 $9,676.05
Disclosure

SEC source: 0001209191-20-034212 · doc4.xml · nonDerivative · entry 3

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,382

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 22:28 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 220 $38.55 $8,481.00
Disclosure

SEC source: 0001209191-20-034212 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,633

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 22:28 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 352 $38.55 $13,569.60
Disclosure

SEC source: 0001209191-20-034212 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,853

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:45 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 981 $45.78 $44,910.18
Disclosure

SEC source: 0001209191-20-015820 · doc4.xml · nonDerivative · entry 3

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,205

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:45 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 215 $45.78 $9,842.70
Disclosure

SEC source: 0001209191-20-015820 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,186

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:45 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 344 $45.78 $15,748.32
Disclosure

SEC source: 0001209191-20-015820 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,401

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020.

Read SEC document
February 28, 2020 Filed May 21, 2020 22:31 UTC Inogen Inc INGN · Entity 2083 GrantRestricted Stock Units · Derivative 21,843 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-031450 · doc4.xml · derivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,843

Underlying: Common Stock · 21,843 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2 · derivative.exercise_date: 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F2 · derivative.expiration_date: 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

Read SEC document
December 01, 2019 Filed Dec 4, 2019 02:46 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 220 $73.61 $16,194.20
Disclosure

SEC source: 0001209191-19-058931 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,745

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2019.

Read SEC document
December 01, 2019 Filed Dec 4, 2019 02:46 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 352 $73.61 $25,910.72
Disclosure

SEC source: 0001209191-19-058931 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,965

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2019.

Read SEC document
September 01, 2019 Filed Sep 5, 2019 01:56 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 220 $46.37 $10,201.40
Disclosure

SEC source: 0001209191-19-048417 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,317

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2019.

Read SEC document
September 01, 2019 Filed Sep 5, 2019 01:56 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 352 $46.37 $16,322.24
Disclosure

SEC source: 0001209191-19-048417 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,537

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2019.

Read SEC document
June 01, 2019 Filed Jun 5, 2019 01:14 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 220 $64.47 $14,183.40
Disclosure

SEC source: 0001209191-19-034605 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,889

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2019.

Read SEC document
June 01, 2019 Filed Jun 5, 2019 01:14 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 352 $64.47 $22,693.44
Disclosure

SEC source: 0001209191-19-034605 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,109

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2019.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:23 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 571 $106.97 $61,079.87
Disclosure

SEC source: 0001209191-19-016183 · doc4.xml · nonDerivative · entry 7

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,461

F5 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2019.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:23 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 229 $106.97 $24,496.13
Disclosure

SEC source: 0001209191-19-016183 · doc4.xml · nonDerivative · entry 6

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,032

F5 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2019.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:23 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 1,202 $106.97 $128,577.94
Disclosure

SEC source: 0001209191-19-016183 · doc4.xml · nonDerivative · entry 5

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,261

F3 · shares: The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with a portion of a performance-based restricted stock award that was earned and vested on March 1, 2019.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:23 UTC Inogen Inc INGN · Entity 2083 GrantCommon Stock 3,543 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-016183 · doc4.xml · nonDerivative · entry 4

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,463

F4 · shares: The reported securities represent shares earned and vested on March 1, 2019 based on achievement of the financial performance conditions for the 2018 fiscal year that were approved as part of the 2018 performance-based restricted stock award granted on March 2, 2018.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:23 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 1,432 $106.97 $153,181.04
Disclosure

SEC source: 0001209191-19-016183 · doc4.xml · nonDerivative · entry 3

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,920

F3 · shares: The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with a portion of a performance-based restricted stock award that was earned and vested on March 1, 2019.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:23 UTC Inogen Inc INGN · Entity 2083 GrantCommon Stock 4,370 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-016183 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,352

F2 · shares: The reported securities represent shares earned and vested on March 1, 2019 based on achievement of the financial performance conditions for the 2018 fiscal year that were approved as part of the 2017 performance-based restricted stock award granted on August 8, 2017.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:23 UTC Inogen Inc INGN · Entity 2083 GrantCommon Stock 9,348 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-016183 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,982

F1 · shares: The reported securities represent shares of restricted stock, 25% of which shall vest on March 1, 2020, and 1/16th of which shall vest every three months thereafter on the 1st day of the month, subject in each case to the reporting person remaining a service provider through each such applicable vesting date.

Read SEC document
December 01, 2018 Filed Dec 3, 2018 22:39 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 352 $147.36 $51,870.72
Disclosure

SEC source: 0001209191-18-060637 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,634

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2018.

Read SEC document
September 01, 2018 Filed Sep 5, 2018 20:47 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 1,490 $264.91 $394,715.90
Disclosure

SEC source: 0001209191-18-049586 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,986

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2018.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 21:10 UTC Inogen Inc INGN · Entity 2083 Exercise / conversionStock Option (right to buy) · Derivative 17,188 $0.00 Strike: $38.54 $0.00
Disclosure

SEC source: 0001209191-18-045343 · doc4.xml · derivative · entry 10

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,375

Underlying: Common Stock · 17,188 shares

Expires 2022-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 21:10 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 1 $203.58 $203.58
Disclosure

SEC source: 0001209191-18-045343 · doc4.xml · nonDerivative · entry 9

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,476

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 21:10 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 1,232 $202.92 $249,996.95
Disclosure

SEC source: 0001209191-18-045343 · doc4.xml · nonDerivative · entry 8

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,477

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F8 · price: Represents the weighted average share price of an aggregate total of 1,232 shares sold in the price range of $202.45 to $203.19 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 21:10 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 7,044 $201.94 $1,422,460.43
Disclosure

SEC source: 0001209191-18-045343 · doc4.xml · nonDerivative · entry 7

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,709

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F7 · price: Represents the weighted average share price of an aggregate total of 7,044 shares sold in the price range of $201.40 to $202.39 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 21:10 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 907 $200.88 $182,197.71
Disclosure

SEC source: 0001209191-18-045343 · doc4.xml · nonDerivative · entry 6

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,753

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F6 · price: Represents the weighted average share price of an aggregate total of 907 shares sold in the price range of $200.32 to $201.21 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 21:10 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 1,795 $199.55 $358,196.92
Disclosure

SEC source: 0001209191-18-045343 · doc4.xml · nonDerivative · entry 5

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,660

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F5 · price: Represents the weighted average share price of an aggregate total of 1,795 shares sold in the price range of $199.15 to $200.14 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 21:10 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 3,008 $198.62 $597,448.06
Disclosure

SEC source: 0001209191-18-045343 · doc4.xml · nonDerivative · entry 4

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,455

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F4 · price: Represents the weighted average share price of an aggregate total of 3,008 shares sold in the price range of $198.15 to $199.12 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 21:10 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 901 $197.35 $177,812.17
Disclosure

SEC source: 0001209191-18-045343 · doc4.xml · nonDerivative · entry 3

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,463

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F3 · price: Represents the weighted average share price of an aggregate total of 901 shares sold in the price range of $197.08 to $197.78 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 21:10 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 2,300 $196.55 $452,072.82
Disclosure

SEC source: 0001209191-18-045343 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,364

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F2 · price: Represents the weighted average share price of an aggregate total of 2,300 shares sold in the price range of $195.97 to $196.89 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 21:10 UTC Inogen Inc INGN · Entity 2083 Exercise / conversionCommon Stock 17,188 $38.54 $662,425.52
Disclosure

SEC source: 0001209191-18-045343 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,664

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:19 UTC Inogen Inc INGN · Entity 2083 Exercise / conversionStock Option (right to buy) · Derivative 9,198 $0.00 Strike: $16.62 $0.00
Disclosure

SEC source: 0001209191-18-027619 · doc4.xml · derivative · entry 9

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,220

Underlying: Common Stock · 9,198 shares

Expires 2021-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:19 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 398 $174.00 $69,252.00
Disclosure

SEC source: 0001209191-18-027619 · doc4.xml · nonDerivative · entry 8

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,476

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:19 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 300 $173.32 $51,995.07
Disclosure

SEC source: 0001209191-18-027619 · doc4.xml · nonDerivative · entry 7

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,874

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F7 · price: Represents the weighted average share price of an aggregate total of 300 shares sold in the price range of $173.00 to $173.68 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:19 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 900 $172.25 $155,022.03
Disclosure

SEC source: 0001209191-18-027619 · doc4.xml · nonDerivative · entry 6

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,174

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F6 · price: Represents the weighted average share price of an aggregate total of 900 shares sold in the price range of $171.90 to $172.67 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:19 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 2,400 $171.16 $410,775.84
Disclosure

SEC source: 0001209191-18-027619 · doc4.xml · nonDerivative · entry 5

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,074

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F5 · price: Represents the weighted average share price of an aggregate total of 2,400 shares sold in the price range of $170.8600 to $171.7225 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:19 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 1,600 $170.34 $272,544.48
Disclosure

SEC source: 0001209191-18-027619 · doc4.xml · nonDerivative · entry 4

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,474

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F4 · price: Represents the weighted average share price of an aggregate total of 1,600 shares sold in the price range of $169.775 to $170.710 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:19 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 2,800 $169.07 $473,397.96
Disclosure

SEC source: 0001209191-18-027619 · doc4.xml · nonDerivative · entry 3

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,074

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F3 · price: Represents the weighted average share price of an aggregate total of 2,800 shares sold in the price range of $168.46 to $169.23 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:19 UTC Inogen Inc INGN · Entity 2083 SaleCommon Stock 800 $167.38 $133,905.04
Disclosure

SEC source: 0001209191-18-027619 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,874

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2017.

F2 · price: Represents the weighted average share price of an aggregate total of 800 shares sold in the price range of $167.01 to $168.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:19 UTC Inogen Inc INGN · Entity 2083 Exercise / conversionCommon Stock 9,198 $16.62 $152,870.76
Disclosure

SEC source: 0001209191-18-027619 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,674

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2018 Filed Mar 6, 2018 22:52 UTC Inogen Inc INGN · Entity 2083 GrantCommon Stock 8,196 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-017419 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,476

F1 · shares: The reported securities represent shares of restricted stock, 25% of which shall vest on March 1, 2019, and 1/16th of which shall vest every three months thereafter on the 1st day of the month, subject in each case to the reporting person remaining a service provider through each such applicable vesting date.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 23:01 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 1,202 $118.33 $142,232.66
Disclosure

SEC source: 0001209191-18-015954 · doc4.xml · nonDerivative · entry 2

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,280

F2 · shares: The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with the portion of the 2017 performance-based restricted stock award that was earned and vested on March 1, 2018.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 23:01 UTC Inogen Inc INGN · Entity 2083 GrantCommon Stock 4,370 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015954 · doc4.xml · nonDerivative · entry 1

Wilkinson Scott · CIK 0001596082 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,482

F1 · shares: The reported securities represent shares earned and vested on March 1, 2018 based on achievement of the financial performance conditions for the 2017 fiscal year that were approved as part of the 2017 performance-based restricted stock award granted on August 8, 2017.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.